Bristol-Myers Squibb is a global BioPharma company focused on discovering, developing and delivering innovative medicines that help patients prevail over serious diseases.
At Bristol-Myers Squibb, the strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company.
BMS has delivered 14 new medicines to patients in the past 10 years.
BMS’s R&D organization is considered among the most productive in the industry. And the String of Pearls strategy of innovative alliances, partnerships and acquisitions further enhances the internal capabilities. BMS’s mission also means working to provide patient access to health care through public/private partnerships like secure the future, the groundbreaking $150 million program to help confront HIV/AIDS in Africa. In addition, through the patient assistance programs, BMS provides free medications to qualifying patients with financial hardship in the U.S.